Fundz

Blue Note Therapeutics, Inc. reported raising $13 Million in an initial SEC Form D filing, from an offering of $30 Million

PRIVATEFeb 12, 2021$13M of $30M raised

Amount Raised

$13 Million

$13 Million sold, per SEC Form D (first sale Feb 12, 2021)

Round Type

Venture

San FranciscoHealthcare

Who to call at Blue Note Therapeutics, Inc., and when

A new round usually means Blue Note Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Blue Note Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Blue Note Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Blue Note Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Blue Note Therapeutics, Inc.

Location

548 MARKET ST., #55709

San Francisco, California, United States

About

Blue Note Therapeutics is a prescription digital therapeutics company singularly dedicated to patients suffering from cancer. We aim to make treatment accessible to any cancer patient, at any time, by merging deep scientific and clinical expertise, neuroscience, and digital innovation. Working closely with cancer research and patient communities, we are developing a pipeline of clinically validated prescription digital therapeutics to help reduce anxiety, depression, and other forms of cancer-related distress. For more information, visit www.bluenotetherapeutics.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Blue Note Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Blue Note Therapeutics, Inc.'s next move

See what Strategic adds

Blue Note Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.